Stay updated on Novel Therapeutics for High-Risk AML Clinical Trial
Sign up to get notified when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.

Latest updates to the Novel Therapeutics for High-Risk AML Clinical Trial page
- Check2 days agoChange DetectedNew entries for Study Status and Contacts/Locations were added to the record history, showing updated status and location/contact details.SummaryDifference0.4%

- Check9 days agoChange DetectedThe study record shows additions and updates to Study Status and Contacts/Locations for recent dates (2026-03-20 to 2026-03-27), reflecting current status and site details.SummaryDifference0.4%

- Check17 days agoChange DetectedThe history adds new version entries (211, 210, 209) with updates to Study Status and Contacts/Locations, and introduces Revision: v3.5.0 (replacing v3.4.3).SummaryDifference0.4%

- Check24 days agoChange DetectedAdded entries show Study Status and Contacts/Locations in the version history, reflecting updates to the trial's status and contact information.SummaryDifference0.4%

- Check31 days agoChange DetectedNew history entries include Study Status (2026-03-05) and Contacts/Locations (2026-03-04) along with Revision: v3.4.3. Revision: v3.4.2 was removed.SummaryDifference0.5%

- Check38 days agoChange DetectedNew history entries were added (versions 192–195). The updates include changes to the Study Status and Contacts/Locations sections.SummaryDifference0.3%

Stay in the know with updates to Novel Therapeutics for High-Risk AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.